Author/Creator: Ning, Shu - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Ning, Shu

1. Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models. (March 2023)

Authors:: Xu, Pengfei; Yang, Joy C.; Ning, Shu; Chen, Bo; Nip, Christopher; Wei, Qiang; Liu, Liangren; Johnson, Oleta T.; Gao, Allen C.; Gestwicki, Jason E.; Evans, Christopher P.; Liu, Chengfei
Journal:: Pharmacological research
Issue:: Volume 189(2023)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. MP27-08 EVALUATING THE EFFICACY OF A NOVEL AKR1C3 INHIBITOR IN PATIENT-DERIVED PROSTATE CANCER CELL LINE AND XENOGRAFT MODELS. (May 2022)

Authors:: Yang, Joy C.; Ning, Shu; Adomat, Hans; Gleave, Martin; Gao, Allen C.; Evans, Christopher P.; Liu, Chengfei
Journal:: Journal of urology
Issue:: Volume 207(2022)Supplement 5
Page Start:: e452
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. PD07-02 TARGETING WNT5A/FZD2 SIGNALING OVERCOMES RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER. (May 2022)

Authors:: Ning, Shu; Liu, Chengfei; Lou, Wei; Lombard, Alan; D'Abronzo, Leandro; Yu, Aiming; Evans, Christopher; Gao, Allen
Journal:: Journal of urology
Issue:: Volume 207(2022)Supplement 5
Page Start:: e98
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗